Authors:
McCormack, JG
Westergaard, N
Kristiansen, M
Brand, CL
Lau, J
Citation: Jg. Mccormack et al., Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy, CUR PHARM D, 7(14), 2001, pp. 1451-1474
Authors:
Schnopper, HW
Silver, E
Murray, S
Romaine, S
Bandler, S
Jones, C
Forman, W
Madden, N
Beeman, J
Haller, E
Christensen, F
Westergaard, N
Fabregat, J
Reglero, V
Gimenez, A
Brosch, N
Liebowitz, E
Netzer, H
Barbera, M
Collura, A
Sciortino, S
Citation: Hw. Schnopper et al., XRASE: The X-Ray Spectroscopic Explorer, ASTRO SP SC, 276(1), 2001, pp. 49-65
Authors:
Madsen, P
Lundbeck, JM
Jakobsen, P
Varming, AR
Westergaard, N
Citation: P. Madsen et al., Glucose-6-phosphatase catalytic enzyme inhibitors: Synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines, BIO MED CH, 8(9), 2000, pp. 2277-2289
Authors:
Waagepetersen, HS
Westergaard, N
Schousboe, A
Citation: Hs. Waagepetersen et al., The effects of isofagomine, a potent glycogen phosphorylase inhibitor, on glycogen metabolism in cultured mouse cortical astrocytes, NEUROCHEM I, 36(4-5), 2000, pp. 435-440
Authors:
Fosgerau, K
Westergaard, N
Quistorff, B
Grunnet, N
Kristiansen, M
Lundgren, K
Citation: K. Fosgerau et al., Kinetic and functional characterization of 1,4-dideoxy-1,4-imino-D-arabinitol: A potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice, ARCH BIOCH, 380(2), 2000, pp. 274-284
Authors:
Andersen, B
Rassov, A
Westergaard, N
Lundgren, K
Citation: B. Andersen et al., Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-d-arabinitol, BIOCHEM J, 342, 1999, pp. 545-550
Authors:
Westergaard, N
Brand, CL
Lewinsky, RH
Andersen, HS
Carr, RD
Burchell, A
Lundgren, K
Citation: N. Westergaard et al., Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo, ARCH BIOCH, 366(1), 1999, pp. 55-60